Novavax（NASDAQ:NVAX）报告季度每股亏损0.51美元，与分析师的共识预期一致。与去年同期每股亏损1.47美元相比，这一数字增加了65.31%。该公司报告季度销售额为8831万美元，超过了分析师共识预期的8438万美元，增幅为4.66%。与去年同期的销售额2.9134亿美元相比，这一数字下降了69.69%。
以上内容来自Benzinga Earnings专栏，原文如下：
Novavax (NASDAQ:NVAX) reported quarterly losses of $(0.51) per share which met the analyst consensus estimate. This is a 65.31 percent increase over losses of $(1.47) per share from the same period last year. The company reported quarterly sales of $88.31 million which beat the analyst consensus estimate of $84.38 million by 4.66 percent. This is a 69.69 percent decrease over sales of $291.34 million the same period last year.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.